Famulok, Michael Max Planck Fellow Chemical Biology, Center of Advanced European Studies and Research (caesar), Max Planck Society;
https://www.nature.com/articles/s41467-018-03631-z (Abstract)
s41467-018-03631-z.pdf (Any fulltext), 2MB
Domenyuk, V., Gatalica, Z., Santhanam, R., Wei, X., Stark, A., Kennedy, P., et al. (2018). Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes. Nature Communications, 9: 1219. doi:10.1038/s41467-018-03631-z.